NPI: 1366406613 · PETERSBURG, VA 23805 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/13/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/13/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,920 | $292K |
| 2019 | 31,094 | $364K |
| 2020 | 31,871 | $441K |
| 2021 | 24,929 | $438K |
| 2022 | 19,732 | $503K |
| 2023 | 18,585 | $457K |
| 2024 | 4,732 | $185K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 46,612 | 3,121 | $2.54M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 48,184 | 2,322 | $76K |
| A4657 | Syringe, with or without needle, each | 13,486 | 2,596 | $40K |
| J1756 | Injection, iron sucrose, 1 mg | 9,417 | 1,708 | $6K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 322 | 137 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 25,781 | 1,847 | $4K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 3,822 | 354 | $3K |
| G0008 | Administration of influenza virus vaccine | 103 | 64 | $455.71 |
| 83970 | 2,300 | 1,302 | $217.49 | |
| 82728 | 1,790 | 1,040 | $85.15 | |
| 90674 | 106 | 66 | $77.77 | |
| 83550 | 1,776 | 1,034 | $45.31 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 307 | 148 | $42.54 |
| 83540 | 1,859 | 1,085 | $33.54 | |
| 0012A | 24 | 15 | $28.39 | |
| 0011A | 34 | 19 | $16.94 | |
| 85041 | 2,367 | 1,419 | $16.67 | |
| 85048 | 2,357 | 1,416 | $13.99 | |
| 82108 | 144 | 89 | $4.09 | |
| 86706 | 33 | 21 | $0.00 | |
| 84466 | 39 | 26 | $0.00 |